Actos Study
2008 Study: Actos Drug Controls Blood Sugar Levels Better than Avandia
Weitz & Luxenberg's Avandia lawyers are currently investigating a study of cases of diabetes patients taking either Avandia or Actos who suffered sudden bone fractures. In addition, the firm is also representing Avandia patients who suffered heart attacks or other heart problems after taking the drug to treat their diabetes.
Please complete the form on this page for more information about your legal rights to file an Avandia/Actos injury lawsuit.
Clinical trial results out of Europe conclude that patients who get a starting dose of diabetes drug Actos, manufactured by Takeda Pharmaceutical, have better control of blood sugar and lipid levels than those who take GlaxoSmithKline's diabetes drug Avandia.
These recent findings were relayed in a medical meeting in Amsterdam. They will likely bolster Takeda's contention that Actos (known generically as pioglitazone) is a better drug than Avandia (known generically as rosiglitazone), which has been linked to heart attack risks.
The study involved an analysis of data from the first three months of a six-month head-to-head study of the two drugs.
It found a starting dose of 30 milligrams of Actos was more effective than a starting dose of 4 milligrams of Avandia in improving blood sugar levels.
Scientists presented the research on the two drugs at the annual meeting of the European Association for the Study of Diabetes.
Weitz & Luxenberg Can Help
If you or a loved one has suffered either a heart attack, stroke, heart failure or other serious heart problems, or developed a fracture after taking Avandia to treat their diabetes, you may be able to seek compensation for their illness, pain and suffering and other financial compensation.
Please complete the form on this page for a free and confidential review of your potential Avandia lawsuit. A Weitz & Luxenberg representative will contact you as soon as possible.
Click To Talk To Us Online
Senate Committee Report
Avandia Recall Prompted by Report Release | Weitz & Luxenberg Attorneys
Potential recall of diabetes drug Avandia due to risk of heart attack. Those affected can get a free lawsuit review from Weitz & Luxenberg.
Veterans Affairs: Avandia
Veterans Affairs Severely Limits Use of GlaxoSmithKline's Avandia Drug
Veterans Affairs Limits Use of Glaxo's Avandia Due to Safety Concerns
News & Warnings
Avandia News and Information | Weitz & Luxenberg
Bloomberg News: FDA Warned Glaxo about Avandia Marketing in 2001